Translate
Oncodesign Precision Medicine S.a.
About
Oncodesign Precision Medicine S.a. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments
Mar 3 2026
Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease
Jan 8 2026
Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases
Dec 29 2025
Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics
Oct 14 2025
OPM Obtains Development Grants From the Bourgogne Franche-Comté Region
Recent Videos
Le Journal des biotechs : Karine Lignel, Jan Hoflack (Oncodesign Precision Medicine)
Mar 18, 2026
How to Buy Oncodesign Precision Medicine Opm SA Stock (ALOPM.PA)
Feb 25, 2026
🏆 Trophées de l'innovation LBPAM : Oncodesign PM remporte le prix "Health Tech"
Nov 26, 2025
SMART BOURSE - Trophées LBP AM : Oncodesign PM, lauréat "Health Tech"
Nov 21, 2025